KAS
NUVB icon

Kestra Advisory Services’s Nuvation Bio NUVB Stock Holding History

Kestra Advisory Services’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+19,340
New +$94.5K ﹤0.01% 3174
2026
Q1 		– Sell
-7,916
Closed -$70.9K – 3983
2025
Q4 		$70.9K Buy
+7,916
New +$49K ﹤0.01% 3700

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Kestra Advisory Services's NUVB Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in Nuvation Bio (NUVB) in Q2 2026: 19,340 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #3174 among its holdings. This is a return to the name: Kestra Advisory Services previously reported a position in NUVB as recently as Q4 2025.

Kestra Advisory Services first reported a position in NUVB in Q4 2025 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Kestra Advisory Services held 19,340 shares of Nuvation Bio worth $110K as of Q2 2026.
  • Nuvation Bio was a new Kestra Advisory Services position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3174 holding.
  • Kestra Advisory Services first reported a position in Nuvation Bio in Q4 2025 and has held it in 2 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.